Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00372463 · ClinicalTrials.gov registry record · Phase 2
Internet Diabetes Self-Management
A Phase 2 study, sponsored by Robert Wood Johnson Foundation.
- Completed
- Registry status
- Phase 2
- Development phase
- 700
- Enrollment target
NCT00372463: Completed Phase 2 study, sponsored by Robert Wood Johnson Foundation.
NCT00372463 is a Phase 2 study that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 700 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (426% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00372463, a Phase 2 study, has completed, sponsored by Robert Wood Johnson Foundation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 700 participants
- Enrollment target
Study Summary
Diabetes is a growing health problem causing personal suffering, comorbid conditions, premature death, and high costs to the individual, the health care system and society. Many of these problems can be prevented or delayed by controlling the disease. This in turn requires daily self-management by patients. We will evaluate an Internet based small group Diabetes Self-Management Program. This program will be adapted from the Chronic Disease Self-Management Program Online, already developed and currently being evaluated by the investigators. Participants with type 2 diabetes will be randomized to participate in the Internet Program or serve as controls continuing with usual care. Treatment subjects will participate in a structured 6 week interactive web-based online class with 20-24 other participants and 2 trained peer moderators. If successful, this project will result in a new and effective means of reaching the CDC objective and more importantly in improving the quality of life and health status of people with diabetes while reducing health care utilization and thus costs.
Interventions
- BEHAVIORAL 6-week Online Diabetes Self-Management Educational Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00372463 record still lists
NCT00372463 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (426% higher).
The record links to 0 conditions, and to 1 intervention - of which 6-week Online Diabetes Self-Management Educational Program is the first listed.
NCT00372463 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00372463 about?
NCT00372463 is a clinical study titled "Internet Diabetes Self-Management". Diabetes is a growing health problem causing personal suffering, comorbid conditions, premature death, and high costs to the individual, the health care system and society. Many of these problems can be prevented or delayed by controlling the disease. This in turn requires daily self-management by p...
What is the current status of trial NCT00372463?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 700 participants. The study started on 2006-02. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00372463?
The interventions under investigation include: 6-week Online Diabetes Self-Management Educational Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00372463?
This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00372463's enrollment target sits among peer trials
700 46th of 2000 higher than 1,955 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia